ClinicalTrials.gg
Drug

Butylphthalide clinical trials

Also written DL-3-n-butylphthalide.

studies test it
22
open now
12
in phase 3
8
first study started
2010

How each study uses butylphthalide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the butylphthalide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Butylphthalide
9
NBP
8
3-n-Butylphthalide
3
NBP Softgel Capsules
2
DL-3-n-butylphthalide (NBP)
2

Development codes

DL-3-n-butylphthalide
5

Other names

dl-NBP
1

In one entry with another drug

Given together, or one or the other

Butylphthalide and Sodium Chloride Injection
2

Studies by the year they started

22 studies that test it; most in 2024 (4)

Studies that test butylphthalide, by start year
YearStudies
20101
20111
20151
20171
20183
20191
20201
20211
20222
20231
20244
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
8
Phase 4
9
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 20

Beijing Tiantan Hospital (2) · Tang Ziren (2) · Yi Yang (1) · CSPC-NBP Pharmaceutical Co., Ltd. (1) · Shanghai 6th People's Hospital (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · Jinling Hospital, China (1) · Nanfang Hospital, Southern Medical University (1)

Often tested with

Tested in the same studies.

Sodium Chloride (2) · Cerebrolysin (1) · Isosorbide mononitrate (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 4 in phase 3

Studies that test butylphthalide, phase 3 first.

Studies

Open first, then newest update. How each study uses butylphthalide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 22

See all 22 studies that test butylphthalide →

Codes

What other systems call butylphthalide · ClinicalTrials.gg INT002847

  • MeSH (NLM) C0271253-n-butylphthalideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 822Q956KGMBUTYLPHTHALIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 1484499Confirmed FDA, Wikidata
  • Wikidata Q5003180butylphthalideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171720ButylphthalideOne source FDA
  • DrugBank DB12749One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.